- Home
- SIMO vs BCYC Comparison
SIMO vs BCYC Comparison
Compare SIMO & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIMO | BCYC |
|---|---|---|
| Founded | 1995 | 2009 |
| Country | Hong Kong | United Kingdom |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 516.8M |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SIMO | BCYC |
|---|---|---|
| Price | $87.07 | $6.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $103.13 | $18.73 |
| AVG Volume (30 Days) | ★ 325.4K | 287.8K |
| Earning Date | 02-04-2026 | 10-30-2025 |
| Dividend Yield | ★ 2.37% | N/A |
| EPS Growth | ★ 8.75 | N/A |
| EPS | ★ 2.87 | N/A |
| Revenue | ★ $798,326,000.00 | $28,339,000.00 |
| Revenue This Year | $10.15 | N/A |
| Revenue Next Year | $17.72 | N/A |
| P/E Ratio | $29.46 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $37.21 | $6.03 |
| 52 Week High | $106.60 | $17.04 |
Technical Indicators
Market Signals| Indicator | SIMO | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 44.03 | 44.11 |
| Support Level | $83.34 | $7.03 |
| Resistance Level | $96.77 | $7.50 |
| Average True Range (ATR) | 3.24 | 0.37 |
| MACD | -0.42 | -0.00 |
| Stochastic Oscillator | 24.35 | 7.69 |
Price Performance
Historical ComparisonAbout SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.